Upstream Bio, Inc.
UPB
$8.56
-$0.09-1.04%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 2.29M | 2.37M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | 2.29M | 2.37M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | 2.29M | 2.37M |
| SG&A Expenses | -- | -- | -- | 13.38M | 12.03M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | -- | 57.29M | 49.29M |
| Operating Income | -- | -- | -- | -55.01M | -46.93M |
| Income Before Tax | -- | -- | -- | -38.62M | -28.63M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -- | -- | -- | -38.62 | -28.63 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | -- | -38.62M | -28.63M |
| EBIT | -- | -- | -- | -55.01M | -46.93M |
| EBITDA | -- | -- | -- | -54.95M | -46.87M |
| EPS Basic | -- | -- | -- | -17.68 | -14.86 |
| Normalized Basic EPS | -- | -- | -- | -8.20 | -6.03 |
| EPS Diluted | -- | -- | -- | -17.68 | -14.86 |
| Normalized Diluted EPS | -- | -- | -- | -8.20 | -6.03 |
| Average Basic Shares Outstanding | -- | -- | -- | 11.80M | 11.74M |
| Average Diluted Shares Outstanding | -- | -- | -- | 11.80M | 11.74M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |